Antibiotics for skin infections: New study design and a step toward shorter course therapy

JAMA

Volumn 309, Issue 6, 2013, Pages 609-611

  Doron, Shira ^a   Boucher, Helen W ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; LINEZOLID; PLACEBO; TEDIZOLID;

ANTIBIOTIC RESISTANCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CELLULITIS; DISEASE ASSOCIATION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; EXPERIMENTAL DESIGN; FOOD AND DRUG ADMINISTRATION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SHORT COURSE THERAPY; SKIN ABSCESS; SKIN INFECTION; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; WOUND INFECTION;

EID: 84873676524     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.604     Document Type: Editorial

References (9)

1. Prokocimer P, De Anda C, Fang E, Mehra P, Das A. Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial. JAMA. 2013;309(6):559-569.
2. Corey GR, Wilcox M, Talbot GH, et al. Integrated analysis of CANVAS 1 and 2. Clin Infect Dis. 2010;51(6):641-650.
3. European Medicines Agency. Addendum to the note for guidance on evaluation of medicinal products indicated for treatment of bacterial infections (CPMP/EWP/558/95 REV 2) to address indication-specific clinical data. http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2012/ 07/WC500129443.pdf. Accessibility verified January 18, 2013.
4. US Department of Health and Human Services; US Food and Drug Administration. Acute bacterial skin and skin structure infections: developing drugs for treatment. http://www.fda.gov/downloads/Drugs/. . ./Guidances/ ucm071185.pdf. Accessibility verified January 18, 2013.
5. Spellberg B, Talbot GH, Boucher HW, et al. Antimicrobial agents for complicated skin and skin-structure infections. Clin Infect Dis. 2009;49(3):383-391.
6. Hepburn MJ, Dooley DP, Skidmore PJ, Ellis MW, Starnes WF, Hasewinkle WC. Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. Arch Intern Med. 2004;164(15):1669-1674.
7. Jenkins TC, Sabel AL, Sarcone EE, et al. Skin and soft-tissue infections requiring hospitalization at an academic medical center. Clin Infect Dis. 2010;51(8):895-903.
8. Katz DE, Lindfield KC, Steenbergen JN, et al. A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria. Int J Clin Pract. 2008;62(9):1455-1464.
9. Infectious Diseases Society of America. The 10 x 20 initiative. Clin Infect Dis. 2010;50(8):1081-1083.